AnovaOS Network Powered Patient Registry
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 100,000
- 试验地点
- 1
- 主要终点
- Assess Clinical, Cost and/or Comparative Effectiveness
研究概览
简要总结
The objective of this study is the development, implementation and management of a registry of patient data that captures clinically meaningful, real-world, data on the diagnosis, nature, course of infection, treatment(s) and outcomes in patients with complex disease globally.
详细描述
The AnovaOS™ Network Powered Patient Registry may be used to inform the development and conduct of clinical trials and observational studies designed to better understand, prevent, diagnose, treat, ameliorate or cure disease. The AnovaOS™ Network Powered Patient Registry may additionally be used to expedite identification and recruitment of participants for clinical trials of promising therapeutics and observational studies.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •18 years old or older;
- •Confirmed positive diagnosis of disease, condition or disorder. This will be self-reported or reported by the patient's provider, advocacy group or other patient representative;
- •Laboratory or other independent means of confirmation is not required but may be confirmed in clinical trials;
- •Able to understand and willing to sign the informed consent document; or whose legal representative has given consent to participate in the research per state and Federal requirements;
- •Willing and able to complete the registry questions or have the instrument(s) completed by an informed proxy;
- •Anticipated additional follow up with the registry once per year.
排除标准
- •Subjects who do not meet the inclusion criteria for the study;
- •Subjects who are unable to understand the protocol or unable to provide legally effective informed consent
结局指标
主要结局
Assess Clinical, Cost and/or Comparative Effectiveness
时间窗: 5 years
Determining clinical effectiveness, cost effectiveness, or comparative effectiveness of a test or a treatment;
Assess Natural history
时间窗: 5 years
Assessing natural history, including estimating the magnitude of a problem; determining the underlying incidence or prevalence rate of a condition; examining trends of disease over time; assessing service delivery and identifying groups at high risk; and describing and estimating survival;
Measuring and/or Improving Quality of Care
时间窗: 5 years
Measuring or improving quality of care, including conducting programs to measure and/or improve the practice of medicine and/or public health.
Assess Safety
时间窗: 5 years
Measuring and monitoring safety and harm associated with the use of specific products and treatments, including conducting comparative evaluation of safety and effectiveness;
次要结局
未报告次要终点